Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-23 07:32 am Purchase | 2024-12-19 | 13G | Personalis, Inc. PSNL | Merck & Co. Inc. MRK | 14,044,943 16.500% | 14,044,943 (New Position) | Filing History |
| 2024-11-06 4:09 pm Purchase | 2024-09-30 | 13G | Evaxion Biotech A/S EVAX | Merck & Co. Inc. MRK | 7,720,588 12.900% | 3,125,000 (+68.00%) | Filing History |
| 2024-02-13 4:55 pm Purchase | 2023-12-29 | 13G | Merck & Co., Inc. MRK | The Vanguard Group | 244,767,034 9.660% | 17,561,056 (+7.73%) | Filing History |
| 2024-01-26 11:49 am Sale | 2023-12-31 | 13G | Merck & Co., Inc. MRK | BlackRock Inc. BLK | 201,836,434 8.000% | -13,174,951 (-6.13%) | Filing History |
| 2024-01-23 3:29 pm Purchase | 2023-12-21 | 13G | Evaxion Biotech A/S EVAX | Merck & Co. Inc. MRK | 4,595,588 11.400% | 4,595,588 (New Position) | Filing History |
| 2023-02-09 10:54 am Purchase | 2022-12-30 | 13G | Merck & Co., Inc. MRK | The Vanguard Group | 227,205,978 8.960% | 16,003,447 (+7.58%) | Filing History |
| 2023-02-03 4:27 pm Purchase | 2022-12-31 | 13G | Merck & Co., Inc. MRK | BlackRock Inc. BLK | 215,011,385 8.500% | 16,787,121 (+8.47%) | Filing History |
| 2022-02-09 3:15 pm Sale | 2021-12-31 | 13G | Merck & Co., Inc. MRK | The Vanguard Group | 211,202,531 8.360% | -7,211,824 (-3.30%) | Filing History |
| 2022-02-02 5:21 pm Purchase | 2021-12-31 | 13G | 4D pharma plc LBPS | Merck & Co. Inc. MRK | 12,145,523 6.600% | 12,145,523 (New Position) | Filing History |
| 2022-01-31 5:59 pm Sale | 2021-12-31 | 13G | Merck & Co., Inc. MRK | BlackRock Inc. BLK | 198,224,264 7.800% | -7,407,803 (-3.60%) | Filing History |
| 2021-03-04 06:06 am Purchase | 2021-02-24 | 13D | PANDION THERAPEUTICS INC PAND | Merck & Co. Inc. MRK | 11,776,706 39.990% | 11,776,706 (New Position) | Filing History |
| 2021-02-10 10:02 am Sale | 2020-12-31 | 13G | Merck & Co., Inc. MRK | The Vanguard Group | 218,414,355 8.240% | -2,234,010 (-1.01%) | Filing History |
| 2021-02-05 08:03 am Purchase | 2020-12-31 | 13G | Merck & Co., Inc. MRK | BlackRock Inc. BLK | 205,632,067 7.800% | 5,691,247 (+2.85%) | Filing History |
| 2021-01-04 2:28 pm Purchase | 2020-12-22 | 13G | Yumanity Therapeutics, Inc. YMTX | Merck & Co. Inc. MRK | 75,286 5.200% | 75,286 (New Position) | Filing History |
| 2020-02-12 09:23 am Purchase | 2019-12-31 | 13G | Merck & Co., Inc. MRK | The Vanguard Group | 220,648,365 8.260% | 5,186,284 (+2.41%) | Filing History |
| 2020-02-05 12:15 pm Sale | 2019-12-31 | 13G | Merck & Co., Inc. MRK | BlackRock Inc. BLK | 199,940,820 7.500% | -3,989,019 (-1.96%) | Filing History |